- Home
- XPOF vs NGEN Comparison
XPOF vs NGEN Comparison
Compare XPOF & NGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XPOF | NGEN |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.6M | 200.0M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | XPOF | NGEN |
|---|---|---|
| Price | $3.73 | $2.00 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $8.13 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 638.3K | 564.1K |
| Earning Date | 05-07-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 35.24 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,092,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.63 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.57 | $1.58 |
| 52 Week High | $9.25 | $5.93 |
Technical Indicators
Market Signals| Indicator | XPOF | NGEN |
|---|---|---|
| Relative Strength Index (RSI) | 32.43 | 42.95 |
| Support Level | N/A | $1.85 |
| Resistance Level | $6.15 | $2.32 |
| Average True Range (ATR) | 0.26 | 0.13 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 14.08 | 6.19 |
Price Performance
Historical ComparisonAbout XPOF Xponential Fitness Inc.
Xponential Fitness Inc is a franchisor of boutique health and wellness brands. It operates a diversified platform of five brands spanning across verticals, including Pilates, barre, stretching, functional training, and yoga. Through its subsidiary, it offers an energetic, accessible, and personalized workout experience led by qualified instructors in studio locations throughout North America and internationally. The company's portfolio of brands includes Club Pilates; StretchLab; YogaSix; Pure Barre; and BFT. It operates in a single segment of the franchise business of its health and wellness brands.
About NGEN NervGen Pharma Corp. Common stock
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.